KRYGER CAPITAL Ltd Takes Position in Surgery Partners, Inc. $SGRY

KRYGER CAPITAL Ltd purchased a new position in Surgery Partners, Inc. (NASDAQ:SGRY) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 100,920 shares of the company’s stock, valued at approximately $2,243,000. Surgery Partners makes up 0.4% of KRYGER CAPITAL Ltd’s investment portfolio, making the stock its 15th largest holding. KRYGER CAPITAL Ltd owned approximately 0.08% of Surgery Partners at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. AlphaQuest LLC raised its holdings in Surgery Partners by 112.0% in the first quarter. AlphaQuest LLC now owns 1,058 shares of the company’s stock worth $25,000 after buying an additional 559 shares during the last quarter. PNC Financial Services Group Inc. grew its holdings in shares of Surgery Partners by 86.4% during the first quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company’s stock valued at $28,000 after buying an additional 542 shares during the last quarter. Summit Securities Group LLC purchased a new stake in shares of Surgery Partners during the first quarter valued at approximately $31,000. DekaBank Deutsche Girozentrale bought a new stake in shares of Surgery Partners during the first quarter valued at approximately $65,000. Finally, FNY Investment Advisers LLC purchased a new position in Surgery Partners in the 2nd quarter worth approximately $115,000.

Insider Buying and Selling at Surgery Partners

In other news, Director Teresa Deluca sold 20,018 shares of Surgery Partners stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $22.74, for a total transaction of $455,209.32. Following the transaction, the director directly owned 45,173 shares of the company’s stock, valued at $1,027,234.02. The trade was a 30.71% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Harrison R. Bane sold 9,339 shares of the stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $22.48, for a total transaction of $209,940.72. Following the completion of the sale, the insider directly owned 117,181 shares of the company’s stock, valued at $2,634,228.88. This represents a 7.38% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 2.70% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on SGRY. JPMorgan Chase & Co. started coverage on Surgery Partners in a research note on Thursday, September 18th. They issued a “neutral” rating and a $27.00 price target for the company. Weiss Ratings restated a “sell (d-)” rating on shares of Surgery Partners in a research note on Wednesday, October 8th. Bank of America started coverage on shares of Surgery Partners in a report on Monday, July 28th. They set a “buy” rating and a $28.00 price target on the stock. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $36.00 price objective on shares of Surgery Partners in a report on Tuesday, October 7th. Five investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $31.14.

Surgery Partners Price Performance

Shares of NASDAQ:SGRY opened at $21.61 on Friday. The company has a quick ratio of 1.78, a current ratio of 1.93 and a debt-to-equity ratio of 1.10. The stock has a market capitalization of $2.77 billion, a PE ratio of -15.11 and a beta of 1.85. The firm’s 50 day moving average price is $21.65 and its 200-day moving average price is $22.15. Surgery Partners, Inc. has a twelve month low of $18.87 and a twelve month high of $31.89.

Surgery Partners (NASDAQ:SGRY) last announced its earnings results on Tuesday, August 5th. The company reported $0.17 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. Surgery Partners had a negative net margin of 5.57% and a positive return on equity of 2.51%. The business had revenue of $826.20 million during the quarter, compared to analysts’ expectations of $816.96 million. During the same period in the prior year, the company earned $0.21 earnings per share. The firm’s revenue was up 8.4% on a year-over-year basis. Equities research analysts expect that Surgery Partners, Inc. will post 0.67 EPS for the current year.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.